What is Interpace Biosciences's Revenue Growth?

• Interpace Biosciences's annual revenue growth as of FY 2023 is 26.31%.
• Interpace Biosciences's quarterly revenue growth as of Q2 2024 is 17.22%.

What is Revenue Growth?

Revenue growth is the increase in a company's sales over a specific period. It's a crucial metric for evaluating a company's financial health and its ability to expand its market presence and generate higher sales.

Related Metrics

Other important metrics to assess Interpace Biosciences's financial performance include:

• Revenue - the total revenue generated by a company:
  • Annual: $40.21M
  • Quarterly: $12.04M
• Cost of Revenue - the total cost of producing the goods or services sold by a company:
  • Annual: $17.17M
  • Quarterly: $4.61M
• Cost of Revenue Growth - the rate at which a company's cost of revenue is growing:
  • Annual Growth: 26.19%
  • Quarterly Growth: 9.73%
• Gross Profit - the difference between revenue and the cost of revenue:
  • Annual: $23.04M
  • Quarterly: $7.43M
• Gross Profit Growth - the rate at which a company's gross profit is growing:
  • Annual Growth: 26.39%
  • Quarterly Growth: 22.40%

These metrics provide insights into Interpace Biosciences's financial health and its ability to generate revenue efficiently. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Historical Annual Revenue Growth

Historical Quarterly Revenue Growth

Historical Annual Revenue

Historical Quarterly Revenue

Historical Annual Cost of Revenue

Historical Quarterly Cost of Revenue

Historical Annual Gross Profit

Historical Quarterly Gross Profit